Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-08-10

FDA Approved: AUVI-Q — Original Application (kaleo, Inc)

View source ↗

Summary

The FDA approved AUVI-Q, an epinephrine autoinjector from Kaleo, under its Original Application for the treatment of anaphylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUVI-Q (Epinephrine)

Snippet

ORIG AP for AUVI-Q (EPINEPHRINE)